Cargando…

Assessment of Unmet Clinical Need in Type 2 Diabetic Patients on Conventional Therapy in the UK

INTRODUCTION: Type 2 diabetes mellitus (T2DM) is an increasing problem worldwide and a leading risk factor for cardiovascular disease. As beta cell function declines, the management of T2DM typically comprises of escalations in treatment from diet and exercise to oral therapies and eventually insuli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bennett, Hayley, McEwan, Phil, Bergenheim, Klas, Gordon, Jason
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269656/ https://www.ncbi.nlm.nih.gov/pubmed/25185770 http://dx.doi.org/10.1007/s13300-014-0079-6

Ejemplares similares

The Health Economic Value of Changes in Glycaemic Control, Weight and Rates of Hypoglycaemia in Type 1 Diabetes Mellitus
por: McEwan, Phil, et al.
Publicado: (2016)

Validation of the UKPDS 82 risk equations within the Cardiff Diabetes Model
por: McEwan, Philip, et al.
Publicado: (2015)

Assessing the economic value of maintained improvements in Type 1 diabetes management, in terms of HbA(1c), weight and hypoglycaemic event incidence
por: McEwan, P., et al.
Publicado: (2018)

Treatment choice, medication adherence and glycemic efficacy in people with type 2 diabetes: a UK clinical practice database study
por: Gordon, Jason, et al.
Publicado: (2018)

Characterizing unmet medical need and the potential role of new biologic treatment options in patients with ulcerative colitis and Crohn’s disease: a systematic review and clinician surveys
por: Gordon, Jason P., et al.
Publicado: (2015)

Assessing the Long-Term Impact of Treating Hepatitis C Virus (HCV)-Infected People Who Inject Drugs in the UK and the Relationship between Treatment Uptake and Efficacy on Future Infections
por: Bennett, Hayley, et al.
Publicado: (2015)

The Cost-Effectiveness of Alogliptin Versus Sulfonylurea as Add-on Therapy to Metformin in Patients with Uncontrolled Type 2 Diabetes Mellitus
por: Gordon, Jason, et al.
Publicado: (2016)

Disutility of injectable therapies in obesity and type 2 diabetes mellitus: general population preferences in the UK, Canada, and China
por: McEwan, Phil, et al.
Publicado: (2022)

Managing glycaemia in older people with type 2 diabetes: A retrospective, primary care‐based cohort study, with economic assessment of patient outcomes
por: Gordon, Jason, et al.
Publicado: (2017)

Liraglutide Therapy for Type 2 Diabetes: Overcoming Unmet Needs
por: Sjöholm, Åke
Publicado: (2010)

Cost-effectiveness of dapagliflozin versus DPP-4 inhibitors as an add-on to Metformin in the Treatment of Type 2 Diabetes Mellitus from a UK Healthcare System Perspective
por: Charokopou, M., et al.
Publicado: (2015)

Evaluation of Insulin Use and Value for Money in Type 2 Diabetes in the United Kingdom
por: Gordon, Jason, et al.
Publicado: (2013)

Modelling the long-term benefits of tolvaptan therapy on renal function decline in autosomal dominant polycystic kidney disease: an exploratory analysis using the ADPKD outcomes model
por: Bennett, Hayley, et al.
Publicado: (2019)

The Unmet Need for Interpreting Provision in UK Primary Care
por: Gill, Paramjit S., et al.
Publicado: (2011)

Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK
por: Linde, Cecilia, et al.
Publicado: (2019)

The cost‐effectiveness of dapagliflozin in treating high‐risk patients with type 2 diabetes mellitus: An economic evaluation using data from the DECLARE‐TIMI 58 trial
por: McEwan, Phil, et al.
Publicado: (2021)

Cost-effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies
por: Pochopien, Michal, et al.
Publicado: (2019)

Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalink
por: Furuland, Hans, et al.
Publicado: (2018)

Diabetes and the brain: issues and unmet needs
por: Bornstein, Natan M., et al.
Publicado: (2014)

Adverse Changes in HbA1c, Body Weight and Insulin Use in People with Type 1 Diabetes Mellitus Following Dapagliflozin Discontinuation in the DEPICT Clinical Trial Programme
por: Gordon, Jason, et al.
Publicado: (2020)

Factors Predictive of Weight Gain and Implications for Modeling in Type 2 Diabetes Patients Initiating Metformin and Sulfonylurea Combination Therapy
por: Gordon, Jason P., et al.
Publicado: (2015)

A Retrospective, Case-Note Survey of Type 2 Diabetes Patients Prescribed Incretin-Based Therapies in Clinical Practice
por: Evans, Marc, et al.
Publicado: (2012)

Cost‐effectiveness of dapagliflozin as a treatment for heart failure with reduced ejection fraction: a multinational health‐economic analysis of DAPA‐HF
por: McEwan, Phil, et al.
Publicado: (2020)

The value of maintaining normokalaemia and enabling RAASi therapy in chronic kidney disease
por: Evans, Marc, et al.
Publicado: (2019)

Cystic fibrosis-related diabetes: The unmet need
por: Pozo, Leonardo, et al.
Publicado: (2020)

Assessing unmet needs in patients with hidradenitis suppurativa
por: Chadha, Simran A., et al.
Publicado: (2023)

Quality of Life and Unmet Need in People with Psychosis in the London Borough of Haringey, UK
por: Lambri, Maria, et al.
Publicado: (2012)

Novel Therapies to Address Unmet Needs in ITP
por: Mingot-Castellano, María Eva, et al.
Publicado: (2022)

Unmet Needs in the Treatment of Childhood Type 2 Diabetes: A Narrative Review
por: Tamborlane, William, et al.
Publicado: (2023)

Unmet needs in asthma
por: Gruffydd-Jones, Kevin
Publicado: (2019)

A study to assess the unmet medical needs associated with the use of basal insulin in patients with type 2 diabetes
por: Frechtel, Gustavo, et al.
Publicado: (2020)

Assessing needs for psychiatric treatment in prisoners: 2. Met and unmet need
por: Jakobowitz, Sharon, et al.
Publicado: (2016)

Unmet clinical needs for COVID-19 tests in UK health and social care settings
por: Graziadio, Sara, et al.
Publicado: (2020)

326. Meeting an unmet need - impact of a Complex Fungal Infection Clinic in the UK
por: Dominic, Catherine, et al.
Publicado: (2023)

Characterizing the relationship between health utility and renal function after kidney transplantation in UK and US: a cross-sectional study
por: Neri, Luca, et al.
Publicado: (2012)

Retrospective Database Analysis Evaluating the Clinical Outcomes of Changing Treatment of People with Type 2 Diabetes Mellitus (T2DM) from Other DPP-4 Inhibitor Therapy to Alogliptin in a Primary Care Setting
por: Strain, W. David, et al.
Publicado: (2019)

An unmet need: tailoring extended adjuvant endocrine therapy
por: Bianchini, G, et al.
Publicado: (2013)

Unmet Needs in Anticoagulant Therapy: Potential Role of Rivaroxaban
por: Eikelboom, John W., et al.
Publicado: (2015)

Raising Gene Therapy for Unmet Medical Needs in Japan
por: Ishii, Tetsuya
Publicado: (2019)

Unmet need for COVID-19 therapies in community settings
por: The Lancet Infectious Diseases
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5er10h4oenb5q9kmppp2ego3in